Laddar...
Interleukin-22 acts as a mitochondrial protector
Interleukin (IL)-22 has been increasingly recognized as a promising therapeutic option for various types of diseases. This commentary summarizes the novel mechanistic aspects of IL-22 for the treatment of liver diseases including the study by Chen et al. published in the recent issue of the Theranos...
Sparad:
| I publikationen: | Theranostics |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Ivyspring International Publisher
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359092/ https://ncbi.nlm.nih.gov/pubmed/32685023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.48022 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|